Cargando…
Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphate
BACKGROUND: Genetically induced hepatocellular carcinoma (HCC) models are generally used to investigate carcinogenesis pathways, but very few attempts were made to valorize them for pharmacological testing. This study describes a micro-computed tomography (micro-CT) - based methodology for the diagn...
Autores principales: | Ignat, Mihaela, Akladios, Cherif Youssef, Lindner, Véronique, Khetchoumian, Konstantin, Teletin, Marius, Muttter, Didier, Aprahamian, Pierre Marc, Marescaux, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041534/ https://www.ncbi.nlm.nih.gov/pubmed/27686696 http://dx.doi.org/10.1186/s13046-016-0434-8 |
Ejemplares similares
-
Impact of myo‐inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models
por: Tran, Ly‐Binh‐An, et al.
Publicado: (2018) -
Tumour angiogenesis normalized by myo‐inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response
por: El Hafny‐Rahbi, Bouchra, et al.
Publicado: (2021) -
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors
por: Schneider, Marcel A., et al.
Publicado: (2021) -
Treatment of hypoxia‐dependent cardiovascular diseases by myo‐inositol trispyrophosphate (ITPP)‐enhancement of oxygen delivery by red blood cells
por: Oknińska, Marta, et al.
Publicado: (2020) -
Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate
por: Oknińska, Marta, et al.
Publicado: (2021)